During the last session, InMed Pharmaceuticals Inc (NASDAQ:INM)’s traded shares were 96024.0, with the beta value of the company hitting 0.27. At the end of the trading day, the stock’s price was $2.51, reflecting an intraday gain of 6.36% or $0.15. The 52-week high for the INM share is $15.70, that puts it down -525.5 from that peak though still a striking 31.47% gain since the share price plummeted to a 52-week low of $1.72. The company’s market capitalization is $3.03M, and the average trade volume was 1.31 million shares over the past three months.

InMed Pharmaceuticals Inc (INM) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 3.00. INM has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it.

InMed Pharmaceuticals Inc (NASDAQ:INM) trade information

InMed Pharmaceuticals Inc (INM) registered a 6.36% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 6.36% in intraday trading to $2.51, hitting a weekly high. The stock’s 5-day price performance is -1.57%, and it has moved by -9.06% in 30 days. Based on these gigs, the overall price performance for the year is -44.64%.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 53.87%.

INM Dividends

InMed Pharmaceuticals Inc is due to release its next quarterly earnings in July. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

The next largest institutional holding, with 86684.0 shares, is of VIRTU FINANCIAL LLC’s that is approximately 0.9017% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $23000.0.